Evidence map›Paper›PMID 26329825›Full record

ArticleScientific reports2015

Measures of kidney function by minimally invasive techniques correlate with histological glomerular damage in SCID mice with adriamycin-induced nephropathy.

Lauren Scarfe, Aleksandra Rak-Raszewska, Stefania Geraci, Darsy Darssan, Jack Sharkey, Jiaguo Huang, Neal C Burton, David Mason, Parisa Ranjzad, Simon Kenny and 7 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Transdermal Measurement of Glomerular Filtration Rate in Mice.Journal of visualized experiments : JoVE · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Lauren ScarfeDepartment of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Aleksandra Rak-RaszewskaDepartment of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Stefania GeraciMedical Research Centre, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Darsy DarssanDepartment of Biostatistics, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Jack SharkeyDepartment of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Jiaguo HuangMedical Research Centre, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Neal C BurtoniThera Medical, Munich, Germany.
David MasonCentre for Cell Imaging, Institute of Integrative Biology, University of Liverpool, Liverpool, UK.
Parisa RanjzadCentre for Paediatrics and Child Health, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK.
Simon KennyDepartment of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Norbert GretzMedical Research Centre, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Raphaël LévyCentre for Cell Imaging, Institute of Integrative Biology, University of Liverpool, Liverpool, UK.
B Kevin ParkDepartment of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Marta García-FiñanaDepartment of Biostatistics, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Adrian S WoolfCentre for Paediatrics and Child Health, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK.
Patricia MurrayDepartment of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Bettina WilmDepartment of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
University of Liverpool · GBHeidelberg University · DEManchester Academic Health Science Centre · GBiThera Medical (Germany) · DE

Funding

Medical Research Council MR/K015931/1Medical Research Council MR/K026739/1Medical Research Council MR/L006758/1
6 · The paper itself

Abstract

Maximising the use of preclinical murine models of progressive kidney disease as test beds for therapies ideally requires kidney function to be measured repeatedly in a safe, minimally invasive manner. To date, most studies of murine nephropathy depend on unreliable markers of renal physiological function, exemplified by measuring blood levels of creatinine and urea, and on various end points necessitating sacrifice of experimental animals to assess histological damage, thus counteracting the principles of Replacement, Refinement and Reduction. Here, we applied two novel minimally invasive techniques to measure kidney function in SCID mice with adriamycin-induced nephropathy. We employed i) a transcutaneous device that measures the half-life of intravenously administered FITC-sinistrin, a molecule cleared by glomerular filtration; and ii) multispectral optoacoustic tomography, a photoacoustic imaging device that directly visualises the clearance of the near infrared dye, IRDye 800CW carboxylate. Measurements with either technique showed a significant impairment of renal function in experimental animals versus controls, with significant correlations with the proportion of scarred glomeruli five weeks after induction of injury. These technologies provide clinically relevant functional data and should be widely adopted for testing the efficacies of novel therapies. Moreover, their use will also lead to a reduction in experimental animal numbers.

Indexed as

Kidney Function TestsAlbuminuriaAnimalsBiomarkersBody WeightDoxorubicinFemaleFluoresceinsHalf-LifeIndolesKidney DiseasesKidney GlomerulusKineticsMice, Inbred BALB CMice, SCIDModels, StatisticalBiomarkersDoxorubicinfluorescein-isothiocyanate sinistrinFluoresceinsIndolesOligosaccharides

Identifiers

PMID26329825
PMCPMC4556979
OpenAlexW2173934646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.